Heart Transplant Recipient Patient with COVID-19 Treated with Tocilizumab

Viral Infections, Non-HIV

Covid-19 in solid organ transplant recipients: A single center experience

Transpl Int.

Hoek RAS, Manintveld OC, Betjes MGH, Hellemons ME, Seghers L, van Kampen JAA, Caliskan K, van de Wetering J, van den Hoogen M, Metselaar HJ, Hesselink DA, Rotterdam Transplant Group.

doi: 10.1111/tri.13662.

Viral Infections, Non-HIV

Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study

QJM.

Rojas-Marte GR, Khalid M, Mukhtar O, Hashmi AT, Waheed MA, Ehrlich S, Aslam A, Siddiqui S, Agarwal C, Malyshev Y, Henriquez-Felipe C, Sharma D, Sharma S, Chukwuka N, Rodriguez DC, Alliu S, Le J, Shani J

doi: 10.1093/qjmed/hcaa206.

Viral Infections, Non-HIV

COVID-19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients

Transpl Infect Dis.

Roberts MB, Izzy S, Tahir Z, Al Jarrah A, Fishman JA, El Khoury J

doi: 10.1111/tid.13407.

Viral Infections, Non-HIV

A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient

Transpl Infect Dis.

Thammathiwat T, Tungsanga S, Tiankanon K, Torvorapanit P, Chumpangern W, Udomkarnjananun S, Avihingsanon Y, Sriprasart T, Srisawat N, Jutivorakool K, Paitoonpong L, Putcharoen O, Townamchai N

doi: 10.1111/tid.13388.

Viral Infections, Non-HIV

Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response

Transpl Infect Dis.

Serrano OK, Kutzler HL, Rochon C, Radojevic JA, Lawlor MT, Hammond JA, Gluck J, Feingold AD, Jaiswal A

doi: 10.1111/tid.13367.

Viral Infections, Non-HIV

Outpatient Management of Kidney Transplant Recipients with Suspected COVID-19- Single Center Experience during the New York City Surge

Transpl Infect Dis.

Mehta SA, Leonard J, Labella P, Cartiera K, Soomro I, Neumann H, Montgomery RA, Ali NM

doi: 10.1111/tid.13383.

Viral Infections, Non-HIV

Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study

Swiss Med Wkly

Sava M, Sommer G, Daikeler T, Woischnig AK, Martinez AE, Leuzinger K, Hirsch H, Erlanger T, Wiencierz A, Bassetti S, Tamm M, Tschudin-Sutter S, Stoeckle M, Pargger H, Siegemund M, Boss R, Zimmer G, Vu DL, Kaiser L, Dell-Kuster S, Weisser M, Battegay M, Hostettler K, Khanna N

doi: 10.4414/smw.2021.20550

Viral Infections, Non-HIV

Clinical Characteristics and Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Case-Control Study

Am J Transplant.

Chaudhry ZS, Williams JD, Vahia A, Fadel R, Acosta TP, Prashar R, Shrivastava P, Khoury N, Corrales JP, Williams C, Nagai S, Abouljoud M, Samaniego-Picota M, Lanfranco OA, Del Busto R, Ramesh MS, Patel A, Alangaden GJ

doi: 10.1111/ajt.16188.

Viral Infections, Non-HIV

Feasibility of Tocilizumab in ICU patients with COVID-19

J Med Virol.

Issa N, Dumery M, Guisset O, Mourissoux G, Bonnet F, Camou F

doi: 10.1002/jmv.26110.

Related content

Covid-19 in solid organ transplant recipients: A single center experience

Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study

COVID-19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients

A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient

Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response

Outpatient Management of Kidney Transplant Recipients with Suspected COVID-19- Single Center Experience during the New York City Surge

Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study

Clinical Characteristics and Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Case-Control Study

Feasibility of Tocilizumab in ICU patients with COVID-19